Stockhead’s ‘Garimpeiro’ columnist Barry FitzGerald is back in the studio for another instalment of The Explorers Podcast.

The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

The ASX dipped again as mining and energy stocks fell, with Paladin Energy slashing its guidance and seeing shares drop more ...

MA Moelis rates Carnaby a Buy with a high target, while RBC gives FireFly an Outperform rating on its Green Bay project.

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for crypto, says US billionaire ...

Bitcoin tops record with bets on $100K by December, amid rumours of a nation-state quietly buying Bitcoin and US Bitcoin ...

Stockhead’s Sarah Hughan sits down with Great Southern Mining (ASX:GSN) managing director Matt Keane to get the short end of ...

Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...

WA's state government has signed a funding agreement that will usher in construction work on a new graphite plant in Collie.

Many Peaks Minerals (ASX:MPK) getting drill rigs spinning at Ferké and Odienné gold projects in Côte d’Ivoire.

LTR Pharma and EZZ Life Sciences have been promoted to a flagship global microcaps index, at the expense of Opthea.